Download Citation
Article Source:
RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial
Keilty D,
Buchanan M,
Ntapolias K,
Aleynikova O,
Tu D,
et al.
(2013)
RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial.
PLOS ONE 8(12): e81740.
https://doi.org/10.1371/journal.pone.0081740